Difference between revisions of "Team:Lethbridge/Demonstrate"

Line 62: Line 62:
 
         <div class="centerContainer">
 
         <div class="centerContainer">
 
             <h1 class="segmentHeader"><span style="font-weight:normal;">Validation Construct</h1>
 
             <h1 class="segmentHeader"><span style="font-weight:normal;">Validation Construct</h1>
 +
 +
<p class="pageText">As an additional tool outside the Next vivo system, we developed a construct that can be used to measure the amount of transcription, translation, or both! The details of this construct can be found on the design page (link).
 +
Using a purified T7 polymerase we in vitro transcribed the full validation construct. After adding DHFBI, the fluorophore, we were able to observe green fluorescence (Figure 2).</p>
 +
 +
<p class="pageText">Will’s spinach figure.</p>
 +
 +
<p class="pageText">Figure 2 - Characterization of the EYFP-Spinach validation construct. </p>
 +
 +
<p class="pageText">From these results we are confident that we can produce the Spinach RNA and use it as a measure of transcriptional activity for our Next vivo system or T7 polymerase alone.</p>
 +
 
</div>
 
</div>
  
Line 68: Line 78:
 
         <div class="centerContainer">
 
         <div class="centerContainer">
 
             <h1 class="segmentHeader"><span style="font-weight:normal;">tRNA Purification</h1>
 
             <h1 class="segmentHeader"><span style="font-weight:normal;">tRNA Purification</h1>
 +
 +
<p class="pageText">The biggest issue we initially faced in developing Next vivo was determining how we could purify tRNA quickly and efficiently. The solution we decided upon was an adapted MS2 purification combined with a subsequent incubation with RNase H and a DNA oligo that would selectively cleavage and release a tRNA of the proper size. For more information on the design, see the tRNA purification section here. (link)</p>
 +
 +
<p class="pageText">Both the tRNAPhe-MS2 construct and MS2BP were expressed individually in E. coli BL21 DE3 cells. Upon which time the cells were lysed, the lysate combined, and applied to a Nickel-sepharose affinity column. The MS2BP is able to bridge the nickel sepharose column and the tRNA-MS2 allowing the tRNA to be isolated from the cell lysate.</p>
 +
 +
<p class="pageText">Graeme’s illustrious post and pre cigarette images of tRNA purification.</p>
 +
 +
<p class="pageText">Figure Y - Whatever Graeme has.
 +
</p>
 +
 
</div>
 
</div>
  

Revision as of 00:33, 29 October 2017



Next vivo was designed in such a way that we could test multiple components and modules individually while developing the full system. These include:

  • Evaluating the efficacy of multiprotein purification using TX-TL proteins
  • Developing a universal tool to characterize TX-TL systems
  • Designing and testing a novel tRNA purification strategy
  • Testing the TX components of our system for activity

Multi-protein Purification

One of the key features of Next vivo is the ability purify all the components in a single step purification. As a proof of concept we expressed four of the TX-TL components and co-purified them all using a nickel sepharose chromatography column (see figure below). The four proteins used in this initial test were selected based on their molecular weights relative to each other for visualization purposes.

Josh’s excellent gel of both overexpression and purification awesomeness.

Figure 1 - Representative overexpression and multiprotein purification of TX-TL components. Each TX-TL component was expressed from E. coli cells carrying the plasmid encoding the specified component and samples three hours post induction were collected (Lane 2-5). The expressing cells of each component were pooled and lysed before applying the lysate to a nickel-sepharose affinity column for isolation of just the polyhistidine tagged TX-TL components. After washing away the unwanted cellular proteins and debris, the TX-TL components were eluted from the Nickel-sepharose to a high level of purity (Lane 6).

From this initial test we have confidence that scaling the multi-protein purification up to include all, or large groups of, the TX-TL proteins will be feasible. The overexpression and purification of these four proteins was done with minimal lab equipment and supplies.

Validation Construct

As an additional tool outside the Next vivo system, we developed a construct that can be used to measure the amount of transcription, translation, or both! The details of this construct can be found on the design page (link). Using a purified T7 polymerase we in vitro transcribed the full validation construct. After adding DHFBI, the fluorophore, we were able to observe green fluorescence (Figure 2).

Will’s spinach figure.

Figure 2 - Characterization of the EYFP-Spinach validation construct.

From these results we are confident that we can produce the Spinach RNA and use it as a measure of transcriptional activity for our Next vivo system or T7 polymerase alone.

tRNA Purification

The biggest issue we initially faced in developing Next vivo was determining how we could purify tRNA quickly and efficiently. The solution we decided upon was an adapted MS2 purification combined with a subsequent incubation with RNase H and a DNA oligo that would selectively cleavage and release a tRNA of the proper size. For more information on the design, see the tRNA purification section here. (link)

Both the tRNAPhe-MS2 construct and MS2BP were expressed individually in E. coli BL21 DE3 cells. Upon which time the cells were lysed, the lysate combined, and applied to a Nickel-sepharose affinity column. The MS2BP is able to bridge the nickel sepharose column and the tRNA-MS2 allowing the tRNA to be isolated from the cell lysate.

Graeme’s illustrious post and pre cigarette images of tRNA purification.

Figure Y - Whatever Graeme has.

Transcription Validation

Future Plans